Prostate Cancer Clinical Trials

Showing 1621-1640 of 2,150 trials

Abiraterone Post Ketoconazole for Prostate Cancer

NCT01199146

This is a phase II, open label, single center study to evaluate the efficacy of abiraterone acetate (CB7630) administered to patients with castrate resistant prostate cancer who have experienced disease progression on ketoconazole. It is hypothesized that abiraterone will be active in patients who have experienced disease progression on ketoconazole

Prostate Cancer

University of California, San Francisco42 participantsStarted Sep 2010

San Francisco, California, United States • Chicago, Illinois, United States

COMPLETEDPhase 1

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

NCT02514213

This is a phase I, open-label trial to evaluate the safety and immunogenicity of INO 5150 alone or in combination with INO-9012 when delivered intramuscularly (IM) followed by electroporation (EP) in men with biochemically relapsed prostate cancer.

Prostate Cancer

Inovio Pharmaceuticals62 participantsStarted Jul 2015

Baltimore, Maryland, United States • Detroit, Michigan, United States • Omaha, Nebraska, United States +7 more locations

Abiraterone Post Ketoconazole for Prostate Cancer

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Related Searches

Prostatectomy Prospective Database

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

Real-Time MV/kV Image Guided Radiation Therapy

MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy

Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate

Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy

Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients

Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia

Carbon-11 Labeled Sarcosine in Prostate Cancer

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

The Effect of ADT on PSMA-PET.

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.